Blood Thinner Duration After Leg Artery Treatment
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests how long patients should take two blood-thinning medications (aspirin and clopidogrel) after treatment to restore blood flow to a severely damaged leg. The goal is to find the right balance between preventing clots and avoiding dangerous bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have severe leg pain or tissue loss from poor blood flow that lasted more than 2 weeks
- Your doctor recently used a catheter-based procedure to open up arteries below your knee to improve blood flow in the last 7 days
- You live in France and have French health insurance
- You do not have a platelet count below 100,000 (a blood cell type important for clotting)
- You are not allergic to aspirin or clopidogrel (Plavix)
- You have no recent serious bleeding, ulcers in your stomach, blood clots in the brain, or other major medical conditions that increase bleeding risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a short course versus a longer course of antiplatelet medicine (blood thinners) after a TAVI procedure for aortic stenosis. It aims to see which approach is safer and more effective.
This Phase 3 trial compares the best “blood thinner” approach for people who have a new clot in the leg (DVT) or lung (PE) and who already take antiplatelet medicines for heart or blood-vessel prevention. It aims to find an antithrombotic plan that lowers clot risk while managing bleeding risk.
This study tests a personalized approach to prevent blood clots in patients who have had surgery to repair blocked arteries in their legs. Researchers want to find the best blood-thinning medication for each individual to reduce serious complications while keeping you safe.
This trial compares two ways to prevent blood clots in people with severe leg blockage (chronic limb-threatening ischemia) who are not having surgery. It tests aspirin alone versus a newer blood thinner (rivaroxaban) plus aspirin, to see which works better in preventing complications.
This study looks at whether giving certain blood-thinning medicines after a leg artery procedure helps prevent serious problems like heart attacks or strokes. It compares different treatment plans to see which is safer and more effective.
This study tests whether a medication called colchicine can help prevent amputation in people with severe leg blood flow problems who just had surgery or a catheter procedure to restore blood flow. Colchicine is an anti-inflammatory drug that may help protect the leg tissue after treatment.
Hear when a new CLTI Defined as Rutherford Category 4 or 5 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.